288 related articles for article (PubMed ID: 27013439)
1. Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode.
Forneris F; Wu J; Xue X; Ricklin D; Lin Z; Sfyroera G; Tzekou A; Volokhina E; Granneman JC; Hauhart R; Bertram P; Liszewski MK; Atkinson JP; Lambris JD; Gros P
EMBO J; 2016 May; 35(10):1133-49. PubMed ID: 27013439
[TBL] [Abstract][Full Text] [Related]
2. Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1.
Craig ML; Waitumbi JN; Taylor RP
J Immunol; 2005 Mar; 174(5):3059-66. PubMed ID: 15728520
[TBL] [Abstract][Full Text] [Related]
3. Identification of complement regulatory domains in vaccinia virus complement control protein.
Mullick J; Bernet J; Panse Y; Hallihosur S; Singh AK; Sahu A
J Virol; 2005 Oct; 79(19):12382-93. PubMed ID: 16160165
[TBL] [Abstract][Full Text] [Related]
4. The structure of complement C3b provides insights into complement activation and regulation.
Abdul Ajees A; Gunasekaran K; Volanakis JE; Narayana SV; Kotwal GJ; Murthy HM
Nature; 2006 Nov; 444(7116):221-5. PubMed ID: 17051152
[TBL] [Abstract][Full Text] [Related]
5. Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1.
Hourcade D; Liszewski MK; Krych-Goldberg M; Atkinson JP
Immunopharmacology; 2000 Aug; 49(1-2):103-16. PubMed ID: 10904110
[TBL] [Abstract][Full Text] [Related]
6. Chimeric CD46/DAF molecules reveal a cryptic functional role for SCR1 of DAF in regulating complement activation.
Christiansen D; Loveland B; Kyriakou P; Lanteri M; Rubinstein E; Gerlier D
Mol Immunol; 2000; 37(12-13):687-96. PubMed ID: 11275254
[TBL] [Abstract][Full Text] [Related]
7. Structural insights on complement activation.
Alcorlo M; López-Perrote A; Delgado S; Yébenes H; Subías M; Rodríguez-Gallego C; Rodríguez de Córdoba S; Llorca O
FEBS J; 2015 Oct; 282(20):3883-91. PubMed ID: 26250513
[TBL] [Abstract][Full Text] [Related]
8. Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2.
Molina H; Kinoshita T; Webster CB; Holers VM
J Immunol; 1994 Jul; 153(2):789-95. PubMed ID: 8021513
[TBL] [Abstract][Full Text] [Related]
9. Regulation of proteolytic activity of complement factor I by pH: C3b/C4b receptor (CR1) and membrane cofactor protein (MCP) have different pH optima for factor I-mediated cleavage of C3b.
Seya T; Okada M; Nishino H; Atkinson JP
J Biochem; 1990 Feb; 107(2):310-5. PubMed ID: 2141838
[TBL] [Abstract][Full Text] [Related]
10. Structure of the C3b binding site of CR1 (CD35), the immune adherence receptor.
Smith BO; Mallin RL; Krych-Goldberg M; Wang X; Hauhart RE; Bromek K; Uhrin D; Atkinson JP; Barlow PN
Cell; 2002 Mar; 108(6):769-80. PubMed ID: 11955431
[TBL] [Abstract][Full Text] [Related]
11. Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack.
Brodbeck WG; Mold C; Atkinson JP; Medof ME
J Immunol; 2000 Oct; 165(7):3999-4006. PubMed ID: 11034410
[TBL] [Abstract][Full Text] [Related]
12. Using mutagenesis and structural biology to map the binding site for the Plasmodium falciparum merozoite protein PfRh4 on the human immune adherence receptor.
Park HJ; Guariento M; Maciejewski M; Hauhart R; Tham WH; Cowman AF; Schmidt CQ; Mertens HD; Liszewski MK; Hourcade DE; Barlow PN; Atkinson JP
J Biol Chem; 2014 Jan; 289(1):450-63. PubMed ID: 24214979
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of Kaposica reveals that bridging of MG2 and CUB domains of target protein is crucial for the cofactor activity of RCA proteins.
Gautam AK; Panse Y; Ghosh P; Reza MJ; Mullick J; Sahu A
Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12794-9. PubMed ID: 26420870
[TBL] [Abstract][Full Text] [Related]
14. Structure-function relationships of complement receptor type 1.
Krych-Goldberg M; Atkinson JP
Immunol Rev; 2001 Apr; 180():112-22. PubMed ID: 11414353
[TBL] [Abstract][Full Text] [Related]
15. Structure-function analysis of the active sites of complement receptor type 1.
Krych M; Hauhart R; Atkinson JP
J Biol Chem; 1998 Apr; 273(15):8623-9. PubMed ID: 9535836
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of target recognition in an innate immune system: interactions among factor H, C3b, and target in the alternative pathway of human complement.
Pangburn MK; Pangburn KL; Koistinen V; Meri S; Sharma AK
J Immunol; 2000 May; 164(9):4742-51. PubMed ID: 10779780
[TBL] [Abstract][Full Text] [Related]
17. Substitution of two amino acids confers C3b binding to the C4b binding site of CR1 (CD35). Analysis based on ligand binding by chimpanzee erythrocyte complement receptor.
Subramanian VB; Clemenza L; Krych M; Atkinson JP
J Immunol; 1996 Aug; 157(3):1242-7. PubMed ID: 8757632
[TBL] [Abstract][Full Text] [Related]
18. Decay-accelerating factor must bind both components of the complement alternative pathway C3 convertase to mediate efficient decay.
Harris CL; Pettigrew DM; Lea SM; Morgan BP
J Immunol; 2007 Jan; 178(1):352-9. PubMed ID: 17182573
[TBL] [Abstract][Full Text] [Related]
19. Synergy between two active sites of human complement receptor type 1 (CD35) in complement regulation: implications for the structure of the classical pathway C3 convertase and generation of more potent inhibitors.
Krych-Goldberg M; Hauhart RE; Porzukowiak T; Atkinson JP
J Immunol; 2005 Oct; 175(7):4528-35. PubMed ID: 16177096
[TBL] [Abstract][Full Text] [Related]
20. Identification of the streptococcal M protein binding site on membrane cofactor protein (CD46).
Giannakis E; Jokiranta TS; Ormsby RJ; Duthy TG; Male DA; Christiansen D; Fischetti VA; Bagley C; Loveland BE; Gordon DL
J Immunol; 2002 May; 168(9):4585-92. PubMed ID: 11971006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
